Pharmaceutical practice of proton pump inhibitors inducing gout recurrence in cancer patients on chemotherapy
The risks of proton pump inhibitors(PPIs)in clinical applications have attracted a growing attention of clinicians.And current focus is placed upon on their potential for drug interactions.Clinical pharmacists systematically evaluated the causal relationship of adverse reactions,summarized the mechanisms and risk factors of PPI-induced gout attacks and developed personal-ized monitoring strategies for lung adenocarcinoma patients on chemotherapy.Through adjusting the variety of acid suppressants,chemotherapeutic cycles of cancer patients might proceed as scheduled,fully reflecting the clinical value of clinical pharmacists.
NETL
NSTL
万方数据
